Why is pain so difficult to treat safely and effectively?

Why do so many pain treatments work in theory but fail in practice?

The biggest challenge is that pain is not one disease—it's a symptom with many causes, and a treatment that targets one mechanism may miss others entirely. For diabetic nerve pain, fewer than one in three patients get adequate relief from existing drugs, and there is no single test to diagnose the condition precisely [6]. This means doctors are often guessing which mechanism is driving a patient's pain, and when they guess wrong, the treatment fails.

Even when a treatment shows promise in early studies, larger trials often reveal modest or inconsistent results. For example, botulinum toxin injections for complex regional pain syndrome reduced pain by about 1 point on a 10-point scale at one month, but the benefit was gone by two to three months, and the studies were too small to detect rare side effects [1]. Similarly, cannabidiol (CBD) for mastocytosis-related pain dropped average scores from 7.3 to 3.8 out of 10, but this was a pilot study with no placebo group, so we don't know how much of that improvement was due to the drug versus natural recovery or the placebo effect [3].

The problem is not that these treatments are useless—it's that their effects are often small, short-lived, or limited to a subset of patients, and we lack reliable ways to predict who will benefit. As one review of sodium channel inhibitors notes, despite strong preclinical data, clinical trials have been disappointing due to issues with drug selectivity, dosing, and off-target side effects [8].

Why is it so hard to find a pain treatment that is both effective and safe?

The safety challenge is that every effective pain intervention carries risks, and those risks can be unpredictable or unacceptable for some patients. In a study of venlafaxine for persistent tooth pain, 80.6% of patients got relief, but 49.6% experienced mild side effects, and 4 patients (3%) had to stop the drug immediately after the first dose due to side effects [2]. That means even a drug that works for most people can be intolerable for a significant minority.

Invasive procedures add another layer of risk. For sacroiliac joint pain in adolescents, steroid injections helped 46% of patients immediately, but 46% had no benefit at all, and one patient experienced a temporary nerve block that caused leg weakness and numbness [7]. The authors note that diagnosis itself is challenging, meaning some patients may undergo risky procedures for a condition they don't even have.

Even non-drug treatments are not risk-free. Acupotomy, a type of acupuncture with a knife-shaped tip, reduced shoulder pain by about 1.2 points on a 10-point scale, but no serious side effects were reported in that study [4]. However, the lack of serious adverse events in a single study does not prove safety—rare complications can only be detected in much larger populations.

Why can't doctors just match the right treatment to the right patient?

Personalizing pain treatment is the holy grail, but we are not there yet. The main obstacle is that we lack reliable biological markers to predict who will respond to what. For diabetic neuropathy, researchers are trying to use detailed sensory profiles to match patients to treatments, but this approach is still experimental [6]. Similarly, sodium channel inhibitors target specific pain pathways, but clinical trials have failed because of poor selectivity and side effects [8].

Timing also matters in ways we don't fully understand. In the venlafaxine study, the only factor that predicted whether a patient would respond was how long they had been in pain—the earlier the treatment, the better the outcome [2]. This suggests that chronic pain may become harder to treat over time, possibly because the nervous system changes, but we don't yet know how to reverse those changes.

Even when treatments work, they often don't work alone. A study of veterans with chronic pain found that psychological treatments like hypnosis and mindfulness meditation improved both pain and sleep, but the improvements happened in parallel, not one causing the other [5]. This means that treating pain may require addressing multiple factors simultaneously—sleep, mood, activity—rather than finding a single magic bullet.

About These Sources

This answer is built on 8 peer-reviewed studies — published from 2021 to 2025, 1 from 2024 or later, 3 in Q1 journals, collectively cited 271 times — selected as the most relevant from 9 studies that passed quality screening, drawn from 45 papers retrieved from a database of over 500 million.

Sources used in this answer

Related research questions